SARS-CoV-2 (COVID-19) Spike RBD antibody [HL1003]
GTX635792
ApplicationsImmunoFluorescence, ELISA, ImmunoCytoChemistry, Neutralisation/Blocking
Product group Antibodies
ReactivityVirus
Overview
- SupplierGeneTex
- Product NameSARS-CoV-2 (COVID-19) Spike RBD antibody [HL1003]
- Delivery Days Customer9
- Application Supplier NoteICC/IF: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, ELISA, ImmunoCytoChemistry, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDHL1003
- Concentration1 mg/ml
- ConjugateUnconjugated
- HostRabbit
- IsotypeIgG
- ReactivityVirus
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Liu TW, Hsu SJ, Hsieh YSY, et al. Polymethoxyflavone from Citrus depressa as an inhibitor against various variants of SARS-CoV-2 spike protein. J Ethnopharmacol. 2024,320:117412. doi: 10.1016/j.jep.2023.117412Read this paper
- Cheedarla N, Verkerke HP, Potlapalli S, et al. Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers. iScience. 2023,26(11):108256. doi: 10.1016/j.isci.2023.108256Read this paper
- Sasaki M, Tabata K, Kishimoto M, et al. S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters. Sci Transl Med. 2023,15(679):eabq4064. doi: 10.1126/scitranslmed.abq4064Read this paper
- Hayashi T, Murakami K, Hirano J, et al. Dasabuvir Inhibits Human Norovirus Infection in Human Intestinal Enteroids. mSphere. 2021,6(6):e0062321. doi: 10.1128/mSphere.00623-21Read this paper
- Tanikawa T, Hayashi T, Suzuki R, et al. Inhibitory effect of honokiol on furin-like activity and SARS-CoV-2 infection. J Tradit Complement Med. 2022,12(1):69-72. doi: 10.1016/j.jtcme.2021.09.005Read this paper